Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 3/20 | 0.41 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | MYC | P01106 | 1/20 | 0.38 |
| ▸ | MAX | P61244 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29439753 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRHDAC1HDAC2GRM5 | |
| Methylene Chloride SCHEMBL28878447 | 0.94 | ALDH1A1 (0.46) | ALDH1A1TSHRHDAC1HDAC2GRM5 | |
| SCHEMBL27510 | 0.83 | ALDH1A1 (0.59) | ALDH1A1TSHRATMTDP1L3MBTL1 | |
| SCHEMBL30967896 | 0.83 | MGLL (0.42) | HDAC1HDAC2GRM5F2MTOR | |
| SCHEMBL3673834 | 0.81 | ATM (0.58) | ALDH1A1HDAC1HDAC2GRM5F2 | |
| SCHEMBL18079795 | 0.81 | CES2 (0.54) | HDAC1HDAC2GRM5F2MTOR | |
| Bromide SCHEMBL31026552 | 0.80 | ALDH1A1 (0.57) | ALDH1A1TSHRATMTDP1L3MBTL1 | |
| Iodide SCHEMBL29916276 | 0.80 | ALDH1A1 (0.57) | ALDH1A1TSHRATMTDP1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL8084573 | 0.80 | ALDH1A1 (0.57) | ALDH1A1TSHRATMTDP1L3MBTL1 | |
| Benzene SCHEMBL9243917 | 0.80 | ALDH1A1 (0.57) | ALDH1A1TSHRATMTDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115708891-B | Developing drug-carrying microsphere based on microfluidic technology and preparation method and application thereof | 四川大学 | 2024-06-18 | — | — | CN | claimed |
| CN-110483503-B | Imidazole carbene ligand with amide remote basic functional group and synthesis method and application thereof | 浙江工业大学 | 2020-11-13 | — | — | CN | claimed |
| CN-110483503-A | Imidazoles carbenes and its synthetic method and application with the long-range basic functionality of amide | UNIV ZHEJIANG TECHNOLOGY | 2019-11-22 | — | — | CN | claimed |
| US-4328162-A | Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound | EASTMAN KODAK COMPANY (US) | 1982-05-04 | — | — | US | claimed |
| US-4323512-A | Process for the preparation of steroidal 17α-arylcarboxylates | SCHERING CORPORATION (US) | 1982-04-06 | — | — | US | claimed |
| US-4252719-A | REMOVAL OF A TERTIARY HYDROGEN FROM A 5-A-STEROID BY CHLORINATING THE STEROID BEING FIRST ESTERIFIED BY AN IODOARYL-CONTAINING ESTERIFICATION AGENT | RESEARCH CORPORATION (US) | 1981-02-24 | — | — | US | claimed |
| US-12617789-B2 | Small molecular inhibitors of NF-κb inducing kinase | JANSSEN PHARMACEUTICA NV (BE) | 2026-05-05 | — | — | US | disclosed |
| US-20260116910-A1 | POLYCYCLIC COMPOUNDS AND METHODS THEREOF | HEPAITECH BEIJING BIOPHARMA TECH CO LTD (CN) | 2026-04-30 | — | — | US | disclosed |
| US-20260021192-A1 | PROTEINS HAVING A COVALENT WARHEAD | TOPAZ THERAPEUTICS INC (US) | 2026-01-22 | — | — | US | disclosed |
| US-20250282785-A1 | PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE | JANSSEN PHARMACEUTICA NV (BE) | 2025-09-11 | — | — | US | disclosed |
| EP-4554941-A1 | HERBICIDAL BENZOXAZINES | FMC Corporation (US) | 2025-05-21 | — | — | EP | disclosed |
| US-12281060-B2 | Remodilins for airway remodeling and organ fibrosis | THE UNIVERSITY OF CHICAGO (US) | 2025-04-22 | — | — | US | disclosed |
| CN-119707930-A | Aromatic ring compound and its prepn and use | 甘李药业股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-4335055-A | Process for the preparation of alkenylbenzene derivatives or alkenylnaphthalene derivatives | CIBA-GEIGY CORPORATION (US) | 1982-06-15 | — | — | US | disclosed |
| US-4328162-A | Process for preparing 9,11-unsaturated steroidal compound from the corresponding saturated steroidal compound | EASTMAN KODAK COMPANY (US) | 1982-05-04 | — | — | US | disclosed |
| US-4323512-A | Process for the preparation of steroidal 17α-arylcarboxylates | SCHERING CORPORATION (US) | 1982-04-06 | — | — | US | disclosed |
| US-4260464-A | Process for the preparation of 17α-(3-iodobenzoyloxy)-9α-chloro-4-pregnene-3,20-diones and their D-homo homologs | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-04-07 | — | — | US | disclosed |
| US-4252719-A | REMOVAL OF A TERTIARY HYDROGEN FROM A 5-A-STEROID BY CHLORINATING THE STEROID BEING FIRST ESTERIFIED BY AN IODOARYL-CONTAINING ESTERIFICATION AGENT | RESEARCH CORPORATION (US) | 1981-02-24 | — | — | US | disclosed |
| US-4252729-A | Steroids and process for their manufacture | HOFFMANN-LA ROCHE INC. (US) | 1981-02-24 | — | — | US | disclosed |
| US-4197406-A | HORMONES | HOFFMANN-LA ROCHE INC. (US) | 1980-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282785-A1 | PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE | NFKBIA, IKBKG, IKBKB | ALDH1A1 4167/4885TSHR 4220/4885HDAC1 993/4885 |
| US-12617789-B2 | Small molecular inhibitors of NF-κb inducing kinase | IRAK3, IKBKB, IKBKG | ALDH1A1 3824/4885TSHR 3881/4885HDAC1 436/4885 |
| US-20260116910-A1 | POLYCYCLIC COMPOUNDS AND METHODS THEREOF | NR1H3, NR1H2, CPT1A | ALDH1A1 598/4885TSHR 495/4885HDAC1 186/4885 |
| US-12281060-B2 | Remodilins for airway remodeling and organ fibrosis | MYLK, MFAP1, FIBP | ALDH1A1 3220/4885TSHR 3401/4885HDAC1 1433/4885 |
| US-20260021192-A1 | PROTEINS HAVING A COVALENT WARHEAD | RIOX2, ORC3, DCLRE1A | ALDH1A1 3714/4885TSHR 2255/4885HDAC1 1786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.